Evidence map›Paper›PMID 34298149›Full record

ArticleTranslational research : the journal of laboratory and clinical medicine2021

Hypophosphatemia in acute liver failure of a broad range of etiologies is associated with phosphaturia without kidney damage or phosphatonin elevation.

Christoph Zechner, Beverley Adams-Huet, Blake Gregory, Javier A Neyra, Jody A Rule, Xilong Li, Jorge Rakela, Orson W Moe, William M Lee, Acute Liver Failure Study Group

Open access · greenAbstract readComparative Study
In one paragraph

Article in Translational research : the journal of laboratory and clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Christoph ZechnerDivision of Endocrinology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA; Department of Pharmacology. UT Southwestern Medical Center, Dallas, Texas, USA; Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, UT Southwestern Medical Center, Dallas, Texas, USA. Electronic address: Christoph.Zechner@UTSouthwestern.edu.
Beverley Adams-HuetCharles and Jane Pak Center for Mineral Metabolism and Clinical Research, UT Southwestern Medical Center, Dallas, Texas, USA; Division of Biostatistics, Population and Data Sciences, Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas, USA.
Blake GregoryDivision of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA; Division of Primary Care, Department of Internal Medicine, Alameda Health System, Oakland, California, USA.
Javier A NeyraCharles and Jane Pak Center for Mineral Metabolism and Clinical Research, UT Southwestern Medical Center, Dallas, Texas, USA; Division of Nephrology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA; Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, USA.
Jody A RuleDivision of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Xilong LiDivision of Biostatistics, Population and Data Sciences, Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas, USA.
Jorge RakelaDivision of Gastroenterology and Hepatology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
Orson W MoeCharles and Jane Pak Center for Mineral Metabolism and Clinical Research, UT Southwestern Medical Center, Dallas, Texas, USA; Division of Nephrology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA; Department of Physiology, UT Southwestern Medical Center, Dallas, Texas, USA.
William M LeeDivision of Digestive and Liver Diseases, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA. Electronic address: William.Lee@UTSouthwestern.edu.
Acute Liver Failure Study Group
Mayo Clinic in Florida · USSouthwestern Medical Center · US

Funding

A Multi-Center Study of Acute Liver Failure in AdultsU01DK058369 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI DURKALSKI, VALERIE L, FONTANA, ROBERT J · 2005 to 2019
$27.4M
UT Southwestern O'Brien Kidney Research Core CenterP30DK079328 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MOE, ORSON W · 2007 to 2021
$16.9M
Pathogenesis of Uric Acid Nephrolithiasis: The Multifaceted Role of Renal LipidsR01DK081423 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MAALOUF, NAIM M, MOE, ORSON W · 2009 to 2023
$6.1M
ENDOCRINE &METABOLISM TRAINING GRANTT32DK007307 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PHILIPP E SCHERER · 1986 to 2026
$5.4M
A MULTI-CENTER THERAPY TRIAL FOR ACUTE LIVER FAILURER01DK058369 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI LEE, WILLIAM M · 2000 to 2004
$4.2M
Klotho and Phosphate in Chronic Kidney Disease: Pathogenesis and TherapeuticsR01DK091392 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI HU, MING-CHANG, MOE, ORSON W · 2011 to 2021
$3.2M
Origin of Excess Acid in Uric Acid UrolithiasisR01DK115703 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI BROWNING, JEFFREY D, MOE, ORSON W · 2019 to 2023
$2.2M
FGF15/FGF19 - γ Klotho FGFR axis in renal phosphate homeostasisK08DK106569 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI ZECHNER, PETER GERHARD CHRISTOPH · 2015 to 2021
$787k
NIDDK NIH HHS K08 DK106569NIDDK NIH HHS P30 DK079328NIDDK NIH HHS R01 DK058369NIDDK NIH HHS R01 DK081423NIDDK NIH HHS R01 DK091392NIDDK NIH HHS R01 DK115703NIDDK NIH HHS T32 DK007307NIDDK NIH HHS U01 DK058369
6 · The paper itself

Abstract

Hypophosphatemia is a common and dangerous complication of acute liver failure (ALF) of various etiologies. While various mechanisms for ALF-associated hypophosphatemia have been proposed including high phosphate uptake into regenerating hepatocytes, acetaminophen (APAP)-associated hypophosphatemia was linked to renal phosphate wasting, and APAP-induced renal tubular injury was proposed as underlying mechanism. We studied 30 normophosphatemic and 46 hypophosphatemic (serum phosphate < 2.5 mg/dL) patients from the Acute Liver Failure Study Group registry with APAP- or non-APAP-induced ALF. Since kidney injury affects phosphate excretion, patients with elevated serum creatinine (>1.2 mg/dL) were excluded. Maximal amount of renal tubular phosphate reabsorption per filtered volume (TmP/GFR) was calculated from simultaneous serum and urine phosphate and creatinine levels to assess renal phosphate handling. Instead of enhanced renal phosphate reabsorption as would be expected during hypophosphatemia of non-renal causes, serum phosphate was positively correlated with TmP/GFR in both APAP- and non-APAP-induced ALF patients (R

Indexed as

AcetaminophenAdultFemaleFibroblast Growth Factor-23Glomerular Filtration RateHumansHypophosphatemiaHypophosphatemia, FamilialKidneyLipocalin-2Liver Failure, AcuteMaleMiddle AgedParathyroid HormonePhosphatesAcetaminophenFGF23 protein, humanFibroblast Growth Factor-23LCN2 protein, humanLipocalin-2Parathyroid HormonePhosphates

Identifiers

PMID34298149
PMCPMC8572166
OpenAlexW3186698219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.